Materia Socio Medica · 2016 · 41 citations · 9 references
PharmacyPharmacologyPharmacotherapyAntimicrobial PharmacotherapyGastrointestinal PharmacotherapyMedical MicrobiologyDiarrhea ManagementProbioticsAcute Diarrhea ManagementAdult Acute Diarrhea TreatmentClinical Trial ReportsComparative Efficacy EvidenceObservational Study AnalysisObservational Study EvaluationProbiotic Safety AssessmentProbiotic Therapy For Diarrhea
BACKGROUND: Nifuroxazide is well known and often used anti-diarrhoeal medicine which has been pushed back from routine practice in recent years and often replaced with probiotics. Even probiotics are accepted and placed in some therapeutic guidelines for diarrhoea treatment, there are no enough evidence for its effectiveness and no comparative efficacy data with nifuroxazide in treatment of acute diarrhea. PATIENTS AND METHODS: live lyophilised lactic-acid bacteria) three times a day for three days. RESULTS: Mean time to last unformed stool (TLUS) in a group which was treated with nifuroxazide was two days, while it took five days for the stool normalisation in the group using probiotic (p=0.0001). CONCLUSIONS: Orally administered nifuroxazide has demonstrated better efficiency as compared to probiotic in treating acute diarrhoea, and both medicines have shown the same safety and tolerance in this study.
9
Bo Svenungsson, Å. Lagergren, Erik Ekwall et al. · Clinical Infectious Diseases · 2000 · 283 citations · Full text
David N. Taylor, A. Louis Bourgeois, Charles D. Ericsson et al. · American Journal of Tropical Medicine and Hygiene · 2006 · 150 citations
Therapy of Travelers' Diarrhea With Rifaximin on Various Continents
Robert Steffen, David A. Sack, Lise Riopel et al. · The American Journal of Gastroenterology · 2003 · 143 citations